Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 9,550 shares at $20.22 ($193K) on 2026-04-17, disclosed to the SEC on 2026-04-20.
Open-market sale of $193k KALV by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |
| KALV | SELL | 2026-02-24 | $312K | — | Filing → |